Novartis buys MorphoSys for €2.7 billion to get cancer drugs
Novartis AG agreed to buy MorphoSys AG for €2.7 billion ($2.9 billion) as the Swiss pharma company starts following through on plans to use bolt-on…
Stay updated with breaking news from None Why. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Novartis AG agreed to buy MorphoSys AG for €2.7 billion ($2.9 billion) as the Swiss pharma company starts following through on plans to use bolt-on…
Anticipation is mounting for more forceful Chinese government efforts to end the nation’s stock rout, with regulators planning to brief President Xi Jinping…
A rally in Chinese shares accelerated after authorities intensified rescue efforts, defying broader weakness in Asia as hopes ebbed for a swift Federal…
Hertz Global Holdings Inc. is looking to cut costs after it missed analysts’ fourth-quarter estimates as it sold down its fleet of Tesla Inc. electric…
DocuSign Inc. is cutting about 6% of its workforce as part of a restructuring effort after talks to sell itself appear to have stalled. • None King Charles…